SkinHealth Systems Inc. (SKIN)
NASDAQ • Healthcare
Last close at October 16, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, SkinHealth Systems Inc. currently loses $4.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 18 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
SkinHealth Systems’ revenue trailed consensus in the second fiscal quarter of 2026, with results reported August 6, 2026, as revenue fell 7.8% to about $72.1 million, led by its HydraFacial skin-treatment platforms and adjacent products. Against expectations, revenue of $72.1 million trailed the $74.5 million estimate, -3.1%. Profitability held up on a gross basis, with gross profit of roughly $49.3 million translating to a gross margin of about 68.4%, while the company posted a net loss of about $2.7 million versus net income of roughly $19.7 million a year ago. Earnings per share were -$0.02, down from $0.15 a year ago. Cash generation remained positive, with operating cash flow of about $2.7 million for the quarter. For the next period, consensus calls for EPS of -$0.07 on revenue of $67.8 million.
Next report — what to expect
SkinHealth Systems Inc. (SKIN) is scheduled to report earnings on November 5, 2026. Wall Street is looking for consensus EPS of -$0.07 on consensus revenue of $67.8 million. For trailing context, revenue declined -7.8% year over year last quarter. SKIN has beaten EPS in 6 of 8 most recent quarters.
About SkinHealth Systems Inc.
SkinHealth Systems Inc. develops aesthetic treatment systems and related digital tools for the healthcare market, trading on the NASDAQ Capital Market as SKIN. The company sells HydraFacial skin-treatment platforms and adjacent products, and it generated $300.8 million of revenue in FY2025.
Today's Snapshot
The day ended with SKIN 16.2% lower at 10.56, while its sector was flat. Volume was about a quarter of its usual level.
Trading Volume
Below 10d avg (320.6K)
88.6K
vs S&P 500 Today
Strong Underperformance
-15.06%
Updated: October 16, 2026 at 20:14 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$11.54 - $18.08Sell
- RSI (14)36.82Neutral
- Stochastic %K (14, 3, 3)41.95Neutral
- MACD Level (12, 26)-0.61Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.